Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075 · see citing works

Apolipoprotein E: Far More Than a Lipid Transport Protein

Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836 · see citing works

Membrane lipid composition and cellular function.

Spector, A. A., & Yorek, M. A. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34276-0 · Cited by 1,485 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

Oxidative stress and Alzheimer disease

Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158 · see citing works

Lipid rafts: bringing order to chaos

PIKE, L. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200021-jlr200 · Cited by 1,139 · see citing works

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K. J., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,135 · see citing works

Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,111 · see citing works

Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 999 · see citing works

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · see citing works

Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics

Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914 · see citing works

Electrospray mass spectrometry of phospholipids

Pulfer, M. K., & Murphy, R. C. (2003) · Mass Spectrometry Reviews · doi:10.1002/mas.10061 · Cited by 909 · see citing works

Alzheimer's Disease--Genotypes, Phenotype, and Treatments

Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 871 · see citing works

Alzheimer's disease: the cholesterol connection

Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 864 · see citing works

Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

Wisniewski, T., & Frangione, B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90444-c · Cited by 802 · see citing works

Oxidative Alterations in Alzheimer's Disease

Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789 · see citing works

A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781 · see citing works

Ceramide in the eukaryotic stress response

Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727 · see citing works

Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype

Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · see citing works

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649 · see citing works

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626 · see citing works

Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability

Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624 · see citing works

Cerebral amyloid deposition and diffuse plaques in ``normal'' aging: Evidence for presymptomatic and very mild Alzheimer's disease

Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603 · see citing works

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 562 · see citing works

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555 · see citing works

Apolipoprotein E and Alzheimer's disease

Strittmatter, W. J., & Roses, A. D. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000413 · Cited by 477 · see citing works

Inflammatory processes in Alzheimer's disease

McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 473 · see citing works

ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition

DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459 · see citing works

Structural Correlates of Cognition in Dementia: Quantification and Assessment of Synapse Change

DeKosky, S. T., Scheff, S. W., & Styren, S. D. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0056 · Cited by 405 · see citing works

Intracellular signal transduction pathways activated by ceramide and its metabolites

Ruvolo, P. P. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00050-1 · Cited by 356 · see citing works

A possible role for plasmalogens in protecting animal cells against photosensitized killing.

Zoeller, R. A., Morand, O. H., & Raetz, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38000-1 · Cited by 348 · see citing works

Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome)

Heymans, H. S. A., Schutgens, R. B. H., Tan, R., van den BOSCH, H., & Borst, P. (1983) · Nature · doi:10.1038/306069a0 · Cited by 348 · see citing works

Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis

Bosio, A., Binczek, E., & Stoffel, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13280 · Cited by 347 · see citing works

Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey

Peters, A., Rosene, D. L., Moss, M. B., Kemper, T. L., Abraham, C. R., Tigges, J., & Albert, M. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00001 · Cited by 344 · see citing works

Vesicular neurotransmitter transporters: from bacteria to humans.

Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 329 · see citing works

Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)

Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327 · see citing works

High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: a fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization

Gross, R. W. (1984) · Biochemistry · doi:10.1021/bi00296a026 · Cited by 297 · see citing works

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

Albers, D. S., & Beal, M. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297 · see citing works

Brain Membrane Phospholipid Alterations in Alzheimer's Disease

Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & McClure, R. J. (2001) · Neurochemical Research · doi:10.1023/a:1011603916962 · Cited by 292 · see citing works

Chemistry and functional distribution of sulfoglycolipids

Ishizuka, I. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00011-8 · Cited by 289 · see citing works

Tandem mass spectrometry in the study of fatty acids, bile acids, and steroids

Griffiths, W. J. (2003) · Mass Spectrometry Reviews · doi:10.1002/mas.10046 · Cited by 288 · see citing works

Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway

Lee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280 · see citing works

Cholesterol and the Biology of Alzheimer's Disease

Wolozin, B. (2004) · Neuron · doi:10.1016/s0896-6273(03)00840-7 · Cited by 275 · see citing works

Ceramide Interaction with the Respiratory Chain of Heart Mitochondria

Di Paola, M., Cocco, T., & Lorusso, M. (2000) · Biochemistry · doi:10.1021/bi9924415 · Cited by 262 · see citing works

Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether

Zoeller, R. A., Lake, A. C., Nagan, N., Gaposchkin, D. P., LEGNER, M. A., & Lieberthal, W. (1999) · Biochemical Journal · doi:10.1042/bj3380769 · Cited by 257 · see citing works

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00931-f · Cited by 248 · see citing works

Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia

Farooqui, A. A., & Horrocks, L. A. (2001) · The Neuroscientist · doi:10.1177/107385840100700308 · Cited by 237 · see citing works

Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease

Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236 · see citing works

Plasmenylethanolamine Facilitates Rapid Membrane Fusion: A Stopped-Flow Kinetic Investigation Correlating the Propensity of a Major Plasma Membrane Constituent to Adopt an HII Phase with Its Ability to Promote Membrane Fusion

Glaser, P. E. A., & Gross, R. W. (1994) · Biochemistry · doi:10.1021/bi00185a019 · Cited by 229 · see citing works

Rapid Plasmenylethanolamine-Selective Fusion of Membrane Bilayers Catalyzed by an Isoform of Glyceraldehyde-3-Phosphate Dehydrogenase: Discrimination between Glycolytic and Fusogenic Roles of Individual Isoforms

Glaser, P. E., & Gross, R. W. (1995) · Biochemistry · doi:10.1021/bi00038a013 · Cited by 210 · see citing works

Bioenergetics of secretory vesicles

Njus, D., Kelley, P. M., & Harnadek, G. J. (1986) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(87)90003-6 · Cited by 209 · see citing works

The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆

Finch, C. E., & Sapolsky, R. M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00053-6 · Cited by 204 · see citing works

Regulation of TRP Channels via Lipid Second Messengers

Hardie, R. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142505 · Cited by 204 · see citing works

Carbonyl Toxicology and Alzheimer's Disease

Picklo, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194 · see citing works

A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease

Lahiri, D. K., Farlow, M. R., Sambamurti, K., Greig, N. H., Giacobini, E., & Schneider, L. S. S. (2003) · Current Drug Targets · doi:10.2174/1389450033346957 · Cited by 185 · see citing works

Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study

Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J., & Muenz, L. R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90152-x · Cited by 183 · see citing works

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

Butterfield, D. A., Debra Boyd-kimball, A., & Castegna, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01948.x · Cited by 183 · see citing works

The protective role of plasmalogens in iron-induced lipid peroxidation

Sindelar, P. J., Guan, Z.-Z., Dallner, G., & Ernster, L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00221-4 · Cited by 181 · see citing works

Characterization and Direct Quantitation of Ceramide Molecular Species from Lipid Extracts of Biological Samples by Electrospray Ionization Tandem Mass Spectrometry

Han, X. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5536 · Cited by 179 · see citing works

Apolipoprotein E suppresses glial cell secretion of TNFα

Laskowitz, D. T., Goel, S., Bennett, E. R., & Matthew, W. D. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00021-0 · Cited by 175 · see citing works

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s disease

Mulder, C., Wahlund, L., Teerlink, T., Blomberg, M. I., Veerhuis, R., van Kamp, G. J., Scheltens, P., & Scheffer, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0007-9 · Cited by 174 · see citing works

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

Poirier, J. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00007-8 · Cited by 162 · see citing works

Mitochondria and ceramide: intertwined roles in regulation of apoptosis

Birbes, H., Bawab, S. E., Obeid, L. M., & Hannun, Y. A. (2002) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(01)00026-7 · Cited by 151 · see citing works

Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling

Ghosh, S., Strum, J. C., & Bell, R. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034165 · Cited by 143 · see citing works

Curvilinear regression course of human brain lipid composition changes with age

Rouser, G., & Yamamoto, A. (1968) · Lipids · doi:10.1007/bf02531202 · Cited by 138 · see citing works

Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs

Han, X., & Gross, R. W. (1990) · Biochemistry · doi:10.1021/bi00472a032 · Cited by 138 · see citing works

Galactolipids are molecular determinants of myelin development and axo-glial organization.

Marcus, J., & Popko, B. (2002) · Biochimica et Biophysica Acta · doi:10.1016/s0304-4165(02)00410-5 · Cited by 131 · see citing works

Modulating Sphingolipid Biosynthetic Pathway Rescues Photoreceptor Degeneration

Acharya, U. R., Patel, S. A., Koundakjian, E. J., Nagashima, K., Han, X., & Acharya, J. (2003) · Science · doi:10.1126/science.1080549 · Cited by 130 · see citing works

Mitochondria in Alzheimer's disease

Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126 · see citing works

Novel Role for Apolipoprotein E in the Central Nervous System

Han, X., Cheng, H., Fryer, J. D., Fagan, A. M., & Holtzman, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212340200 · Cited by 126 · see citing works

Cerebellar atrophy in Alzheimer's disease—clinicopathological correlations

Węgiel, J., Wı́sniewski, H. M., Dziewíatkowski, J., Badmajew, E., Tarnawski, M. J., Reisberg, ‌., Mlodzik, B., de Leon, M. J., & Miller, D. C. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01279-7 · Cited by 123 · see citing works

Apolipoprotein E: a major piece in the Alzheimer's disease puzzle

Cedazo-Mínguez, A., & Cowburn, R. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00159.x · Cited by 122 · see citing works

The biological significance of plasmalogens in defense against oxidative damage

Brosche, T., & Platt, D. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00014-x · Cited by 119 · see citing works

New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau

Yanker, B. A. (1996) · Nature Medicine · doi:10.1038/nm0896-850 · Cited by 119 · see citing works

Alzheimer's disease: β‐Amyloid protein and tau

Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 116 · see citing works

Phospholipid composition and levels are altered in down syndrome brain

Murphy, E. J., Schapiro, M. B., Rapoport, S. I., & Shetty, H. U. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02205-8 · Cited by 114 · see citing works

Apolipoprotein E, Amyloid, and Alzheimer Disease

Bales, K. R. (2002) · Molecular Interventions · doi:10.1124/mi.2.6.363 · Cited by 113 · see citing works

Free-Radical-Induced Oxidation of Arachidonoyl Plasmalogen Phospholipids: Antioxidant Mechanism and Precursor Pathway for Bioactive Eicosanoids

Murphy, R. C. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000250t · Cited by 112 · see citing works

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia

Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003) · Annals of Neurology · doi:10.1002/ana.10618 · Cited by 111 · see citing works

Alzheimer’s Disease and the Cerebellum: A Morphologic Study on Neuronal and Glial Changes

Sjöbeck, M., & Englund, E. M. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051260 · Cited by 105 · see citing works

Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action

Menaldino, D. S. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00054-9 · Cited by 100 · see citing works

Cytokines in Sickle Cell Disease

Pathare, A. V., Alkindi, S. S. A., Daar, S., & Dennison, D. (2003) · Hematology · doi:10.1080/10245330310001604719 · Cited by 95 · see citing works

Long‐term potentiation requires activation of calcium‐independent phospholipase A2

Wolf, M. J., Izumi, Y., Zorumski, C. F., & Gross, R. W. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01371-7 · Cited by 92 · see citing works

Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.

Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90 · see citing works

Membrane Instability, Plasmalogen Content, and Alzheimer's Disease

Ginsberg, L., Xuereb, J. H., & Gershfeld, N. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062533.x · Cited by 89 · see citing works

Yin and Yang: complement activation and regulation in Alzheimer’s disease

Shen, Y., & Meri, S. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.08.001 · Cited by 89 · see citing works

Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids*

Sawamura, N., Ko, M., Yu, W., Zou, K., Hanada, K., Suzuki, T., Gong, J., Yanagisawa, K., & Michikawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309832200 · Cited by 88 · see citing works

Membrane Components Separate Early-Onset Alzheimer’s Disease From Senile Dementia of the Alzheimer Type

Gottfries, C., Karlsson, I., & Svennerholm, L. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002736 · Cited by 85 · see citing works

Galactosphingolipids and axono-glial interaction in myelin of the central nervous system

Bosio, A., Büssow, H., Adam, J., & Stoffel, W. (1998) · Cell and Tissue Research · doi:10.1007/s004410051051 · Cited by 81 · see citing works

Peroxisomal Impairment in Niemann-Pick Type C Disease

Schedin‐Weiss, S., Sindelar, P. J., Pentchev, P. G., Brunk, U. T., & Dallner, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6245 · Cited by 80 · see citing works

Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis

Vit, J., & Rosselli, F. (2003) · Oncogene · doi:10.1038/sj.onc.1207087 · Cited by 76 · see citing works

Acid Sphingomyelinase-derived Ceramide Signaling in Apoptosis

Gulbins, E., & Kolesnick, R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47931-1_12 · Cited by 74 · see citing works

Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques

van Horssen, J., Kleinnijenhuis, J., Maass, C., Rensink, A. A. M., Otte‐Höller, I., David, G., van den Heuvel, L. P. W. J., Wesseling, P., de Waal, R. M. W., & Verbeek, M. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00010-6 · Cited by 73 · see citing works

Membrane dynamics, cholesterol homeostasis, and Alzheimer's disease

Chauhan, N. B. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300010-jlr200 · Cited by 72 · see citing works

Cholesterol Published, JLR Papers in Press, January 23, 2003. DOI 10.1194/jlr.R300007-JLR200

Raffaı̈, R., & Weisgraber, K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300007-jlr200 · Cited by 72 · see citing works

Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion

Glaser, P. E. A., Han, X., & Gross, R. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222542999 · Cited by 71 · see citing works

The role of apolipoprotein E in lipid metabolism in the central nervous system

Han, X.-L. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4009-z · Cited by 70 · see citing works

Lipoproteins and lipid peroxidation in Alzheimer's disease.

Bassett, C. N., & Montine, T. J. (2003) · PubMed · Cited by 67 · see citing works

Characterization of cysteine residues and disulfide bonds in proteins by liquid chromatography/electrospray ionization tandem mass spectrometry

Yen, T., Joshi, R. K., Yan, H. F., Seto, N. O. L., Palcic, M. M., & Macher, B. A. (2000) · Journal of Mass Spectrometry · doi:10.1002/1096-9888(200008)35:8 · Cited by 67 · see citing works

Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia

Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02017-9 · Cited by 66 · see citing works

Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia

Fredman, P., Wallin, A., Blennow, K., Davidsson, P., Gottfries, C. G., & Svennerholm, L. T. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb04006.x · Cited by 65 · see citing works

The Role of Cholesterol and Statins in Alzheimer's Disease

Miller, L. J., & Chacko, R. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d104 · Cited by 63 · see citing works

Cross-talk between Phosphatidylinositol 3-Kinase and Sphingomyelinase Pathways as a Mechanism for Cell Survival/Death Decisions

Burow, M. E., Weldon, C. B., Collins‐Burow, B. M., Ramsey, N. W., McKee, A. S., Klippel, A., McLachlan, J. A., Clejan, S., & Beckman, B. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9628 · Cited by 63 · see citing works

Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration

Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.007 · Cited by 62 · see citing works

Inhibition of peroxyl radical–mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol

Hahnel, D., Beyer, K., & Engelmann, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00142-2 · Cited by 60 · see citing works

Magnetic Resonance Spectroscopic Changes in Alzheimer's Diseasea

Pettegrew, J. W., Klunk, W. E., Panchalingam, K., McCLURE, R. J., & Stanley, J. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48480.x · Cited by 58 · see citing works

Monoclonal Antibody to Embryonic CNS Antigen A2B5 Provides Evidence for the Involvement of Membrane Components at Sites of Alzheimer Degeneration and Detects Sulfatides as Well as Gangliosides

Majocha, R. E., Jungalwala, F. B., Rodenrys, A., & Marotta, C. A. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11798.x · Cited by 52 · see citing works

Dramatic increase of α-hydroxyaldehydes derived from plasmalogens in the aged human brain

Weisser, M., Vieth, M., Stolte, M., Riederer, P. F., Pfeuffer, R., Leblhuber, F., & Spiteller, G. (1997) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00089-3 · Cited by 48 · see citing works

Oxidative Mechanisms in β-Amyloid Cytotoxicity

Davis, J. B. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0060 · Cited by 47 · see citing works

Anti-inflammatory effects of sulfatides in selectin-dependent acute lung injury

Mulligan, M. S., Miyasaka, M., Suzuki, M., Kawashima, H., lizuka, M., Hasegawa, A., Kiso, M., Warner, R. L., & Ward, P. A. (1995) · International Immunology · doi:10.1093/intimm/7.7.1107 · Cited by 47 · see citing works

Free Fatty Acids, Neutral Glycerides, and Phosphoglycerides in Transient Focal Cerebral Ischemia

Zhang, J., & Sun, G. Y. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041688.x · Cited by 45 · see citing works

Functional role of phospholipids in the nuclear events

Alessenko, A. V., & Burlakova, E. B. (2002) · Bioelectrochemistry · doi:10.1016/s1567-5394(02)00135-4 · Cited by 44 · see citing works

Cholesterol, Synaptic Function and Alzheimer’s Disease

Koudinov, A. R., & Koudinova, N. V. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43055 · Cited by 43 · see citing works

Nonmonotonic alterations in the fluorescence anisotropy of polar head group labeled fluorophores during the lamellar to hexagonal phase transition of phospholipids

Han, X., & Gross, R. W. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81616-8 · Cited by 40 · see citing works

Possible Link between Lipid Metabolism and Cerebral Amyloid Angiopathy in Alzheimer’s Disease: A Role for High-Density Lipoproteins?

Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40 · see citing works

Synaptic Transmission and Cellular Signaling

Holz, R. W., & Fisher, S. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00012-2 · Cited by 38 · see citing works

Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide

Ditaranto-Desimone, K., Saito, M., Tekirian, T. L., Saito, M., Berg, M. J., Dubowchik, G. M., Soreghan, B. A., Thomas, S. N., Marks, N., & Yang, A. J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00948-6 · Cited by 36 · see citing works

Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimer's disease

Mattson, M. P. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53014-2 · Cited by 33 · see citing works

Proton nuclear magnetic resonance studies on the molecular dynamics of plasmenylcholine/cholesterol and phosphatidylcholine/cholesterol bilayers

Han, X., & Gross, R. W. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90362-c · Cited by 33 · see citing works

Reconstitution of membrane fusion between pancreatic islet secretory granules and plasma membranes: Catalysis by a protein constituent recognized by monoclonal antibodies directed against glyceraldehyde-3-phosphate dehydrogenase

Han, X., Ramanadham, S., Turk, J., & Gross, R. W. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00154-0 · Cited by 31 · see citing works

Protein kinase C isoforms and lipid second messengers: a critical nuclear partnership?

Neri, L. M., Borgatti, P., Capitani, S., & Martelli, A. M. (2002) · PubMed · doi:10.14670/hh-17.1311 · Cited by 30 · see citing works

Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease

Farooqui, A. A., & Horrocks, L. A. (1998) · Biochemical Society Transactions · doi:10.1042/bst0260243 · Cited by 28 · see citing works

Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium

Scherrer, L. A., & Gross, R. W. (1989) · Molecular and Cellular Biochemistry · doi:10.1007/bf00223430 · Cited by 27 · see citing works

A turn of the sulfatide in Alzheimer's disease

Irizarry, M. C. (2003) · Annals of Neurology · doi:10.1002/ana.10642 · Cited by 27 · see citing works

Sphingolipids as differential regulators of cellular signalling processes

Pyne, S., Tolan, D., Conway, A.-M., & Pyne, N. J. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250549 · Cited by 26 · see citing works

Cholesterol, a Modulator of Membrane‐Associated Aβ‐Fibrillogenesis

McLaurin, J., Darabie, A. A., & Morrison, M. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04840.x · Cited by 25 · see citing works

[46] Synthesis and biological activity of glycolipids, with a focus on gangliosides and sulfatide analogs

Ikami, T., Ishida, H., & Kiso, M. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)11105-x · Cited by 20 · see citing works

Chemical and magnetic inequivalence of glycerol protons in individual subclasses of choline glycerophospholipids: implications for subclass-specific changes in membrane conformational states

Han, X., Chen, X., & Gross, R. W. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00019a003 · Cited by 20 · see citing works

Alzheimer's disease: its origin at the membrane, evidence and questions.

Buchet, R., & Pikuła, S. (2000) · Acta Biochimica Polonica · doi:10.18388/abp.2000_3991 · Cited by 20 · see citing works

Sphingolipids In Vascular Biology

Argraves, K. M., Obeid, L. M., & Hannun, Y. A. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_68 · Cited by 20 · see citing works

Sulfated Galactocerebrosides as Potential Antiinflammatory Agents

Marinier, A., Martel, A. M., Banville, J., Bachand, C., Rémillard, R., Lapointe, P., Turmel, B., Ménard, M., Harte, W. E., Wright, J. J. K., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9606960 · Cited by 17 · see citing works

Effect of Lipid Structure on the Capacity of Myelin Basic Protein to Alter Vesicle Properties: Potent Effects of Aliphatic Aldehydes in Promoting Basic Protein‐Induced Vesicle Aggregation

Epand, R. M., Dell, K. R., Surewicz, W. K., & Moscarello, M. A. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06077.x · Cited by 16 · see citing works

Aβ conformational change is central to Alzheimer’s disease

Holtzman, D. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00040-4 · Cited by 10 · see citing works

Sphingomyelin and ceramide in brain aging, neuronal plasticity and neurodegenerative disorders

Mattson, M. P., & Cutler, R. G. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12006-8 · Cited by 9 · see citing works

Phospholipid composition and levels are not altered in fibroblasts bearing presenilin-1 mutations

Murphy, E. J., Zhang, H., Sorbi, S., Rapoport, S. I., & Gibson, G. E. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00257-4 · Cited by 4 · see citing works

Reflections on the Great Plasmalogen Puzzle: Effector Mediated Signal Transduction Coupled to Glyceride Structures

Rapport, M. M. (1998) · Neurochemical Research · doi:10.1023/a:1022441029834 · Cited by 4 · see citing works

Ceramide-driven stress signals in cancer and aging

Ruvolo, P. P., Johnson, C. R., & Jarvis, W. D. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12004-4 · Cited by 2 · see citing works

Untitled work

Cole (2000) · doi:10.1002/1097-0029(20000815)50:4

Functions of plasmalogen lipids in health and disease

Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082 · see citing works

Structural and functional roles of ether lipids

Dean, J. M., & Lodhi, I. J. (2017) · Protein & Cell · doi:10.1007/s13238-017-0423-5 · Cited by 682 · see citing works

Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences

Yang, K., & Han, X. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.08.010 · Cited by 596 · see citing works

Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy

Zheng, W., Kollmeyer, J., Symolon, H., Momin, A. A., Munter, E., Wang, E. L., Kelly, S. L., Allegood, J. C., Liu, Y., Peng, Q., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.009 · Cited by 561 · see citing works

Multi‐dimensional mass spectrometry‐based shotgun lipidomics and novel strategies for lipidomic analyses

Han, X., Yang, K., & Gross, R. W. (2011) · Mass Spectrometry Reviews · doi:10.1002/mas.20342 · Cited by 530 · see citing works

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429 · see citing works

Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview

Mazza, M., Pomponi, M., Janiri, L., Bria, P., & Mazza, S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.07.010 · Cited by 306 · see citing works

Novel advances in shotgun lipidomics for biology and medicine

Wang, M., Wang, C., Han, R. H., & Han, X. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.12.002 · Cited by 269 · see citing works

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia

Goodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D., Ahiahonu, P. W. K., Heath, D., Yamazaki, Y., Flax, J., Krenitsky, K. F., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.p700023-jlr200 · Cited by 253 · see citing works

The foundations and development of lipidomics

Han, X., & Gross, R. W. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100164 · Cited by 250 · see citing works

Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

Martins, I., Berger, T. R., Sharman, M., Verdile, G., Fuller, S., & Martins, R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06408.x · Cited by 237 · see citing works

The physiological functions of human peroxisomes

Wanders, R. J. A., Baes, M., Ribeiro, D., Ferdinandusse, S., & Waterham, H. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00051.2021 · Cited by 228 · see citing works

Peroxisomal alterations in Alzheimer’s disease

Kou, J., Kovacs, G. G., Höftberger, R., Kulik, W., Brodde, A., Forss-Petter, S., Hönigschnabl, S., Gleiss, A., Brügger, B., Wanders, R., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0836-9 · Cited by 227 · see citing works

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 213 · see citing works

The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases

Smith, E. L., & Schuchman, E. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-108043 · Cited by 213 · see citing works

Alzheimer’s disease: the lipid connection

Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 199 · see citing works

Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology

Naudí, A., Cabré, R., Jové, M., Ayala, V., Gonzalo‐Benito, H., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.05.008 · Cited by 199 · see citing works

Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease

Zhang, L., Trushin, S., Christensen, T. A., Bachmeier, B. V., Gateno, B., Schroeder, A., Yao, J., Itoh, K., Sesaki, H., Poon, W. W., et al. (2016) · Scientific Reports · doi:10.1038/srep18725 · Cited by 198 · see citing works

Peroxisomes in brain development and function

Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194 · see citing works

TREM2 dependent and independent functions of microglia in Alzheimer’s disease

Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191 · see citing works

Plasmalogens and Chronic Inflammatory Diseases

Bozelli, J. C., Azher, S., & Epand, R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730829 · Cited by 180 · see citing works

Plasmalogens and Alzheimer’s disease: A review

Su, X. Q., Wang, J., & Sinclair, A. J. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1044-1 · Cited by 172 · see citing works

Lipidomics of Alzheimer's disease: current status

Wood, P. L. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt103 · Cited by 167 · see citing works

Sphingolipids: Critical players in Alzheimer’s disease

van Echten‐Deckert, G., & Walter, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.07.001 · Cited by 172 · see citing works

From peroxisomal disorders to common neurodegenerative diseases – the role of ether phospholipids in the nervous system

Dorninger, F., Forss‐Petter, S., & Berger, J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12788 · Cited by 162 · see citing works

Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease

Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 158 · see citing works

Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease

Han, X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.01.010 · Cited by 154 · see citing works

Tutorial on lipidomics

Wang, J., Wang, C., & Han, X. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.01.043 · Cited by 146 · see citing works

Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?

Mielke, M. M., & Lyketsos, C. G. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8121-y · Cited by 141 · see citing works

Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration

Dorninger, F., Forss‐Petter, S., Wimmer, I., & Berger, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105061 · Cited by 139 · see citing works

Yeast sphingolipids: Recent developments in understanding biosynthesis, regulation, and function

Cowart, L. A., & Obeid, L. M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.08.005 · Cited by 133 · see citing works

Metabolic and molecular aspects of ethanolamine phospholipid biosynthesis: the role of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2)

Bakovic, M., Fullerton, M. D., & Michel, V. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-006 · Cited by 129 · see citing works

Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment

Qiu, S., Palavicini, J. P., Wang, J., Gonzalez, N. S., He, S., Dustin, E., Zou, C., Ding, L., Bhattacharjee, A., Skike, C. E. V., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00488-7 · Cited by 126 · see citing works

Glycosphingolipid FunctionsPreprint

Lingwood, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004788 · Cited by 123 · see citing works

Associative and predictive biomarkers of dementia in HIV-1–infected patients

Bandaru, V. V. R., McArthur, J. C., Sacktor, N. C., Cutler, R. G., Knapp, E. E., Mattson, M. P., & Haughey, N. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260610.79853.47 · Cited by 115 · see citing works

Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits

Yang, D.-S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J. A., Pawlik, M., Huo, C., Walkley, S. U., Saito, M., Cuervo, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu278 · Cited by 114 · see citing works

Neurolipidomics: challenges and developments

Han, X. (2006) · Frontiers in bioscience · doi:10.2741/2258 · Cited by 110 · see citing works

Consumption of a high‐fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice

Borg, M. L., Omran, S. F., Weir, J. M., Meikle, P. J., & Watt, M. J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.233288 · Cited by 108 · see citing works

Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration

Arboleda, G., Morales, L. C., Benítez, B. A., & Arboleda, H. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.10.001 · Cited by 105 · see citing works

Multidimensional Mass Spectrometry-Based Shotgun Lipidomics

Wang, M., & Han, X. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1258-2_13 · Cited by 104 · see citing works

Low Vitamin K Intakes in Community-Dwelling Elders at an Early Stage of Alzheimer's Disease

Presse, N., Shatenstein, B., Kergoat, M., & Ferland, G. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.09.013 · Cited by 104 · see citing works

Specific changes of sulfatide levels in individuals with pre‐clinical Alzheimer's disease: an early event in disease pathogenesis

Cheng, H., Wang, M., Li, J., Cairns, N. J., & Han, X. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12368 · Cited by 103 · see citing works

Generation of Alzheimer Disease-associated Amyloid β42/43 Peptide by γ-Secretase Can Be Inhibited Directly by Modulation of Membrane Thickness

Winkler, E., Kamp, F., Scheuring, J., Ebke, A., Fukumori, A., & Steiner, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356659 · Cited by 101 · see citing works

Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics

Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04708.x · Cited by 101 · see citing works

Recent advances in lipidomics for disease research

Li, Y., Li, M., Shan, Y., Shen, S., Bai, Y., & Liu, H. (2015) · Journal of Separation Science · doi:10.1002/jssc.201500899 · Cited by 97 · see citing works

Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens

Dorninger, F., Brodde, A., Braverman, N., Moser, A. B., Just, W. W., Forss‐Petter, S., Brügger, B., & Berger, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.005 · Cited by 96 · see citing works

Genetic Ablation of Calcium-independent Phospholipase A2γ Leads to Alterations in Hippocampal Cardiolipin Content and Molecular Species Distribution, Mitochondrial Degeneration, Autophagy, and Cognitive Dysfunction

Mancuso, D. J., Kotzbauer, P. T., Wozniak, D. F., Sims, H. F., Jenkins, C. M., Guan, S., Han, X., Yang, K., Sun, G., Malik, I., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055194 · Cited by 96 · see citing works

Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology

Wood, P. L. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.167 · Cited by 94 · see citing works

Shotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applications

Hu, C., Wang, M., & Han, X. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.030 · Cited by 91 · see citing works

Sphingolipid Storage Affects Autophagic Metabolism of the Amyloid Precursor Protein and Promotes Aβ Generation

Tamboli, I. Y., Hampel, H., Tien, N. T., Tolksdorf, K., Breiden, B., Mathews, P. M., Säftig, P., Sandhoff, K., & Walter, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2954-10.2011 · Cited by 90 · see citing works

Disturbed neurotransmitter homeostasis in ether lipid deficiency

Dorninger, F., König, T., Scholze, P., Berger, M. L., Zeitler, G., Wiesinger, C., Gundacker, A., Pollak, D. D., Huck, S., Just, W. W., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz040 · Cited by 88 · see citing works

Impaired Plasmalogens in Patients with Schizophrenia

Kaddurah-Daouk, R., McEvoy, J., Baillie, R., Zhu, H., K. Yao, J., Nimgaonkar, V. L., Buckley, P. F., Keshavan, M. S., Georgiades, A., & Nasrallah, H. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.019 · Cited by 89 · see citing works

Identification and Quantitation of Unsaturated Fatty Acid Isomers by Electrospray Ionization Tandem Mass Spectrometry: A Shotgun Lipidomics Approach

Yang, K., Zhao, Z., Gross, R. W., & Han, X. (2011) · Analytical Chemistry · doi:10.1021/ac2006119 · Cited by 89 · see citing works

The importance of ether-phospholipids: A view from the perspective of mouse models

da Silva, T. F., Sousa, V., Malheiro, A. R., & Brites, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.014 · Cited by 86 · see citing works

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

Tumani, H., Teunissen, C. E., Süßmuth, S. D., Otto, M., Ludolph, A. C., & Brettschneider, J. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.479 · Cited by 83 · see citing works

Evidence for Premature Lipid Raft Aging in APP/PS1 Double-Transgenic Mice, a Model of Familial Alzheimer Disease

Fabelo, N., Martín, M. V., Marín, R., Santpere, G., Aso, E., Ferrer, I., & Díaz, M. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826be03c · Cited by 75 · see citing works

Studies on Plasmalogen-Selective Phospholipase A2 in Brain

Farooqui, A. A. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8091-y · Cited by 72 · see citing works

Long-Term Performance and Stability of Molecular Shotgun Lipidomic Analysis of Human Plasma Samples

Heiskanen, L., Suoniemi, M., Ta, H. X., Tarassov, K., & Ekroos, K. (2013) · Analytical Chemistry · doi:10.1021/ac401857a · Cited by 72 · see citing works

Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging

Dorninger, F., Moser, A. B., Kou, J., Wiesinger, C., Forss-Petter, S., Gleiss, A., Hinterberger, M., Jungwirth, S., Fischer, P., & Berger, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171036 · Cited by 70 · see citing works

The Vinyl Ether Linkages of Plasmalogens Are Favored Targets for Myeloperoxidase-Derived Oxidants: A Kinetic Study

Skaff, O., Pattison, D. I., & Davies, M. J. (2008) · Biochemistry · doi:10.1021/bi800786q · Cited by 71 · see citing works

Early Biochemical and Morphological Modifications in the Brain of a Transgenic Mouse Model of Alzheimer's Disease: A Role for Peroxisomes

Cimini, A., Moreno, S., D’Amelio, M., Cristiano, L., D’Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1199 · Cited by 68 · see citing works

Lipidomic characterization of extracellular vesicles in human serum

Chen, S., Chaudhuri, A. D., Deme, P., Dickens, A. M., Dastgheyb, R. M., Bhargava, P., Bi, H., & Haughey, N. J. (2019) · Journal of Circulating Biomarkers · doi:10.1177/1849454419879848 · Cited by 69 · see citing works

Long‐chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes

Wang, G., Silva, J., Dasgupta, S., & Bieberich, E. (2008) · Glia · doi:10.1002/glia.20626 · Cited by 67 · see citing works

Sphingolipids in apoptosis, survival and regeneration in the nervous system

de Chaves, E. I. P. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.018 · Cited by 66 · see citing works

Reassessment of Pioglitazone for Alzheimer’s Disease

Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 67 · see citing works

Plasmalogens Eliminate Aging-Associated Synaptic Defects and Microglia-Mediated Neuroinflammation in Mice

Gu, J., Chen, L., Sun, R., Wang, J., Wang, J., Lin, Y., Lei, S., Zhang, Y., Lv, D., Jiang, F., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.815320 · Cited by 65 · see citing works

Abundance of triacylglycerols in ganglia and their depletion in diabetic mice: implications for the role of altered triacylglycerols in diabetic neuropathy

Cheng, H., Guan, S., & Han, X. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03794.x · Cited by 62 · see citing works

Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease

Farooqui, A. A., Ong, W., & Farooqui, T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.002 · Cited by 56 · see citing works

Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer’s disease

Xu, X., Huang, Y. M., Wang, G., & Chen, S. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1272-0 · Cited by 57 · see citing works

RECOGNITION AND AVOIDANCE OF ION SOURCE‐GENERATED ARTIFACTS IN LIPIDOMICS ANALYSIS

Hu, C., Luo, W., Xu, J., & Han, X. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21659 · Cited by 56 · see citing works

Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift

Dorninger, F., Werner, E. R., Berger, J., & Watschinger, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.946393 · Cited by 54 · see citing works

Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model

Wang, H., Lian, K., Han, B., Wang, Y., Kuo, S., Geng, Y., Qiang, J., Sun, M., & Wang, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131463 · Cited by 53 · see citing works

Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?

Marín, R., Rojo, J. A. P., Fabelo, N., Fernandez, C. E., & Díaz, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.025 · Cited by 49 · see citing works

Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease

Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 48 · see citing works

Lipid-based biomarkers for CVD, COPD, and aging – A translational perspective

Ekroos, K., Lavrynenko, O., Titz, B., Pater, C., Hoeng, J., & Ivanov, N. V. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101030 · Cited by 46 · see citing works

Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model

Hu, C., Du, Y., Xu, X., Li, H., Duan, Q., Xie, Z., Wen, C., & Han, X. (2021) · Metabolites · doi:10.3390/metabo11030142 · Cited by 46 · see citing works

Recent advances in the mass spectrometric analysis of glycosphingolipidome – A review

Barrientos, R. C., & Zhang, Q. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.05.051 · Cited by 42 · see citing works

Glucosylceramide synthase decrease in frontal cortex of Alzheimer brain correlates with abnormal increase in endogenous ceramides: Consequences to morphology and viability on enzyme suppression in cultured primary neurons

Marks, N., Berg, M. J., Saito, M., & Saito, M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.066 · Cited by 41 · see citing works

Reduced muscle strength in ether lipid‐deficient mice is accompanied by altered development and function of the neuromuscular junction

Dorninger, F., Herbst, R., Kravić, B., Camurdanoglu, B. Z., Mačinković, I., Zeitler, G., Forss‐Petter, S., Strack, S., Khan, M. M., Waterham, H. R., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14082 · Cited by 41 · see citing works

The protection of indolealkylamines from LPS-induced inflammation in zebrafish

Zhang, Y., Takagi, N., Yuan, B., Zhou, Y., Si, N., Wang, H., Yang, J. T., Wei, X., Zhao, H., & Bian, B. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112122 · Cited by 41 · see citing works

Alterations in phosphatidylethanolamine levels affect the generation of Aβ

Nesic, I., Guix, F. X., Vennekens, K., Michaki, V., Veldhoven, P. P. V., Feiguin, F. M., Strooper, B. D., Dotti, C. G., & Wahle, T. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00760.x · Cited by 41 · see citing works

Novel strategies for enhancing shotgun lipidomics for comprehensive analysis of cellular lipidomes

Hu, C., Wang, C., He, L., & Han, X. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.11.028 · Cited by 39 · see citing works

Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease

François, M., Leifert, W. R., Hecker, J. R., Faunt, J., Martins, R. N., Thomas, P., & Fenech, M. F. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22453 · Cited by 39 · see citing works

The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging

Hancock, S. E., Friedrich, M. G., Mitchell, T. W., Truscott, R. J. W., & Else, P. L. (2017) · GeroScience · doi:10.1007/s11357-017-9961-2 · Cited by 39 · see citing works

How Do Ethanolamine Plasmalogens Contribute to Order and Structure of Neurological Membranes?

West, A., Zoni, V., Teague, W. E., Leonard, A. N., Vanni, S., Gawrisch, K., Tristram‐Nagle, S., Sachs, J. N., & Klauda, J. B. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b08850 · Cited by 38 · see citing works

Endosomes and lysosomes play distinct roles in sulfatide-induced neuroblastoma apoptosis: potential mechanisms contributing to abnormal sulfatide metabolism in related neuronal diseases

Zeng, Y., Cheng, H., Jiang, X., & Han, X. (2008) · Biochemical Journal · doi:10.1042/bj20070976 · Cited by 38 · see citing works

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

Jové, M., Mota‐Martorell, N., Òbis, È., Sol, J., Martin‐Garí, M., Ferrer, I., Portero‐Otín, M., & Pamplona, R. (2023) · Antioxidants · doi:10.3390/antiox12020293 · Cited by 37 · see citing works

Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome

Filho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 39 · see citing works

Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis

Ayciriex, S., Djelti, F., Alves, S., Regazzetti, A., Gaudin, M., Varin, J., Langui, D., Bièche, I., Hudry, E., Dargère, D., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00211 · Cited by 37 · see citing works

Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau

Kling, M. A., Goodenowe, D. B., Senanayake, V. K., MahmoudianDehkordi, S., Arnold, M., Massaro, T., Baillie, R., Han, X., Leung, Y. Y., Saykin, A. J., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12110 · Cited by 36 · see citing works

Lipids under stress – a lipidomic approach for the study of mood disorders

Miranda, A. M., & Oliveira, T. G. (2015) · BioEssays · doi:10.1002/bies.201500070 · Cited by 35 · see citing works

Molecular and biophysical features of hippocampal “lipid rafts aging” are modified by dietary n‐3 long‐chain polyunsaturated fatty acids

Díaz, M. L., Pereda, D., Valdés‐Baizabal, C., Santos, G., & Marín, R. (2023) · Aging Cell · doi:10.1111/acel.13867 · Cited by 33 · see citing works

Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 35 · see citing works

Octyl Gallate Markedly Promotes Anti-Amyloidogenic Processing of APP through Estrogen Receptor-Mediated ADAM10 Activation

Zhang, S., Sawmiller, D. R., Li, S., Rezai-Zadeh, K. P., Hou, H., Zhou, S., Shytle, R. D., Giunta, B. N., Fernandez, F., Mori, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071913 · Cited by 34 · see citing works

Amyloid-β Peptide Triggers Membrane Remodeling in Supported Lipid Bilayers Depending on Their Hydrophobic Thickness

Meker, S., Chin, H., Sut, T. N., & Cho, N. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b01196 · Cited by 33 · see citing works

Sphingosine 1‐phosphate in neural signalling and function

Milstien, S., Gude, D., & Spiegel, S. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00206.x · Cited by 32 · see citing works

Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer’s disease

Choi, B. J., Park, M. H., Jin, H. K., & Bae, J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01176-4 · Cited by 31 · see citing works

Sulfatides facilitate apolipoprotein E‐mediated amyloid‐β peptide clearance through an endocytotic pathway

Zeng, Y., & Han, X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05481.x · Cited by 29 · see citing works

Omega‐3 fatty acids modulate the lipid profile, membrane architecture, and gene expression of leiomyoma cells

Islam, M. S., Castellucci, C., Fiorini, R., Greco, S., Gagliardi, R., Zannotti, A., Giannubilo, S. R., Ciavattini, A., Frega, N. G., Pacetti, D., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26537 · Cited by 28 · see citing works

Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma

Khan, M. J., Codreanu, S. G., Goyal, S., Wages, P. A., Gorti, S. K. K., Pearson, M. J., Uribe, I. R., Sherrod, S. D., MCLEAN, J. A. J., Porter, N. A., et al. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8911 · Cited by 28 · see citing works

Specific changes of sulfatide levels in individuals with pre‐clinical Alzheimer's disease: an early event in disease pathogenesis

Cheng, H., Wang, M., Li, J., Cairns, N. J., & Han, X. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12368 · Cited by 103 · see citing works

What can lipidomics tell us about the pathogenesis of Alzheimer disease?

Xiang, Y., Lam, S. M., & Shui, G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0207 · Cited by 27 · see citing works

Lipidome alteration as a hallmark and therapeutic target in Alzheimer’s disease

He, S., & Han, X. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00709

Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?

Senanayake, V. K., & Goodenowe, D. B. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.08.003 · Cited by 50 · see citing works

Roles of Cholesterol and Lipids in the Etiopathogenesis ofAlzheimer′s Disease

Rojo, L. E., Sjöberg-Herrera, M. K., Hernández, P., Zambrano, C. A., & Maccioni, R. B. (2006) · BioMed Research International · doi:10.1155/jbb/2006/73976 · Cited by 57 · see citing works